A rise in government funding for genomics projects and increasing R&D activities based on genomics are the key growth drivers
Market Size – USD 18.60 Billion in 2019
Market Growth – CAGR of 13.1%
Market Trends – Advancements in medical research
The global genomics market is expected to be valued at USD 47.23 Billion by 2027. Genomics refers to the study of genetics and the whole genomes of various organisms. It combines different DNA sequencing methods, recombinant DNA, and bioinformatics in order to assemble, sequence, and analyze the structure and functions of genomes. The growing adoption of genetically modified plants and animals for medical research and experiments, increasing genetic procedures, emergence of innovative machines, and augmented government funding for health research & development activities are the primary factors inducing the global market growth. The rising trend of personalized medicine, technological advancements in genomics, increasing focus of research institutions on genomic data integration, and the development of liquid biopsy tests have further boosted the market growth.
Numerous other factors like cancer screening-based research, rising application of genomics in medicine, the escalating number of human genomics studies, growing number of healthcare companies focusing on medical genomics, diminishing sequencing costs, and the entry of new market players in the genomics field are further expected to bolster the global genomics market growth. Several biotechnology companies focus on using advanced gene-editing tools to address the challenges associated with personalized medicine and genetically engineered and recombinant products. Moreover, the rising focus of agriculture research institutes and forensic centers on genomics is another key propeller for the global market growth.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2975
Key Findings of the Report:
- Based on the deliverable type, the NGS-based services sub-segment leads the global genomics market in terms of revenue share. Surging adoption of whole-genome sequencing, increasing applications of sequence databases for disease prognosis, and growing participation of biotechnology & pharmaceutical companies, academic and research centers, and CROs in genomics research are the key factors contributing to the growth of this segment.
- The polymerase chain reaction (PCR) segment is the most dominant segment in terms of technology. The simplicity and efficiency of this technology and its significant role in sequencing, cloning, and analysis are the leading factors behind this segment’s growth. The technology also finds application in the study of various alterations of gene expression levels in microbes, tumors, and other disease forms.
- Based on application, the agriculture and animal research segment is the key market segment. Various agriculture and animal research centers use fundamental information related to genomics to stimulate animals’ responses.
- Among the various end-users, the pharmaceutical and biotechnology companies segment leads the global genomics market. Pharmaceutical and biotechnology companies worldwide employ the available information pertaining to genomics in personalized medicine. Moreover, reduced costs of sequencing have made whole-genome sequencing relatively more affordable for these companies. These are the crucial factors contributing to this segment’s growth.
- Leading competitors in the global genomics market include Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, Oxford Nanopore Technologies, Qiagen, Eurofins Scientific, Danaher Corporation, Bio-Rad Laboratories, F. Hoffmann-La Roche, and GE Healthcare.
Early Diners Are Offered Free Customization
Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/2975
For the purpose of this report, the global genomics market is segmented based on deliverable type, technology, application, end-user, and region:
Deliverable Type Outlook (Revenue, USD Billion; 2017-2027)
- Products
- Instruments
- Reagents
- Services
- Core Genomics
- NGS-based
- Computational
- Biomarker Translation
- Others
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Polymerase chain reaction (PCR)
- Sequencing
- Nucleic Acid Extraction and Purification
- Microarray
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Diagnostics
- Agriculture & Animal Research
- Precision Medicine
- Drug Discovery & Development
- Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Pharmaceutical and biotechnology companies
- Research centers and government institutes
- Others
Buy this Report Now @ https://www.reportsanddata.com/checkout-form/2975
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- US.
- Canada
- Europe
- UK.
- France
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Get Insights into Our Other Trending HealthCare Reports:
Life Science Analytics Market Analysis By Type (Descriptive, Prescriptive, Predictive), By Component (Software, Service), By Delivery Model (On-Demand Model, On-Premise Model), By Application (Research & Development, Sales & Marketing, Clinical Trials, Pharmacovigilance, Others), By End-User (Medical Device Companies, Research Centers, Others), And By Region, Forecasts To 2027
Corporate Wellness Market Analysis By Service (Health Risk Assessment, Smoking Cessation, Fitness, Stress Management, Others), By Category (Fitness & Nutrition Consultants, Psychological Therapists, Organizations/Employers), By End-User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations), By Delivery Model (Offsite, Onsite), By Region, Forecast To 2027
Human Growth Hormone Market Size, Growth & Analysis By Product Type (Powder, Solvent), By Route of Administration (Subcutaneous, Intravenous, Oral, Intramuscular), By Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Idiopathic Short Stature, Others), By Distribution Channel (Hospitals, Online Pharmacies, Retail Pharmacies), By Region, Forecast To 2027
Ask for your specific company profile and country level customization on reports.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Facebook | LinkedIn | Twitter | Blogs